DaVita Inc

DVANYSE · USD
174.56USD0.00 (+0.29%)
1069

DaVita Inc (DVA) Covered Calls

DaVita Inc trades in the Medical Care Facilities industry with an IV Rank of 44.05%, average versus the past year. DVA's highest covered call setup is the $200.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 8.99% out of the money with 9 days to expiration, a 9.10% return until expiration, and a 369.09% theoretical annualized return. Across the setups shown, annualized returns run from 134.16% to 369.09% at strikes between $190.00 and $290.00, with 9 to 156 days to expiration, as of Nov 11, 2026.

Read more

Running DVA covered calls helps you generate income from DaVita Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best DVA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If DVA stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling DVA covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given DVA covered call is worth writing.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services.

2026-11-209200.008.990.201.451670.009.10369.09-0.11+0.134801.25
2026-11-209195.006.270.500.901200.006.54265.21-0.27+0.143,5410.40
2026-12-1837230.0025.340.100.604660.0025.40250.52-0.05+0.044050.50
2026-12-1837220.0019.890.252.603675.0020.03197.57-0.14+0.122242.35
2026-11-209190.003.541.202.50770.004.20170.18-0.65+0.296551.30
2027-02-19100260.0041.690.052.857655.0041.72152.27-0.03+0.0862.80
2026-12-1837210.0014.440.801.502730.0014.88146.76-0.44+0.122,2660.70
2027-01-1565230.0025.340.251.854675.0025.48143.06-0.14+0.092,2311.60
2027-04-16156290.0058.040.052.9510655.0058.07135.86-0.03+0.0702.90
2027-02-19100250.0036.240.952.106745.0036.76134.16-0.52+0.09541.15

As of Nov 11, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryMedical Care Facilities
  • SectorHealthcare
  • IV Rank44.05% Moderate
  • Market cap (M$)10,980
  • 52 weeks high-29.47%
  • 52 weeks low72.83%
  • Analyst recommendationBuy
    2.36
  • Target price$231.83
    32.81% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2027-02-01
  • P/E13.20
  • Future P/E10.48
  • EPS (ttm)13.22
  • EPS growth next 5 years21.99%

As of Nov 13, 2026